Olmesartan medoxomil ameliorates sciatic nerve regeneration in diabetic rats. 2009

Hiroaki Nakamura, and Yuki Domon, and Tatsuya Inoue, and Naohisa Arakawa, and Tomihisa Yokoyama
Biological Research Laboratories II, R&D Division Daiichi-Sankyo Co. Ltd., Tokyo, Japan. nakamura.hiroaki.xn@daiichisankyo.co.jp

To evaluate the effect of angiotensin II type1 receptor blocker on nerve regeneration delay in diabetic rats, nerve regeneration was monitored by a pinch test on the crushed sciatic nerves of streptozotocin-induced diabetic rats. Nerve regeneration was significantly delayed in diabetic rats and was partly ameliorated by treatment with olmesartan medoxomil (3 mg/kg/day, orally). In the ipsilateral dorsal root ganglia, the mRNA level of insulin-like growth factor-1 and ciliary neurotrophic factor (CNTF) was downregulated, whereas the mRNA level of neurotrophin-3 and CNTF receptor was upregulated. Olmesartan medoxomil significantly enhanced the CNTF expression. These results showed that angiotensin II type1 receptor blocker treatment is effective on nerve regeneration delay in diabetic animals and may provide an effective therapy for clinical diabetic neuropathy.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D007839 Functional Laterality Behavioral manifestations of cerebral dominance in which there is preferential use and superior functioning of either the left or the right side, as in the preferred use of the right hand or right foot. Ambidexterity,Behavioral Laterality,Handedness,Laterality of Motor Control,Mirror Writing,Laterality, Behavioral,Laterality, Functional,Mirror Writings,Motor Control Laterality,Writing, Mirror,Writings, Mirror
D008297 Male Males
D009416 Nerve Regeneration Renewal or physiological repair of damaged nerve tissue. Nerve Tissue Regeneration,Nervous Tissue Regeneration,Neural Tissue Regeneration,Nerve Tissue Regenerations,Nervous Tissue Regenerations,Neural Tissue Regenerations,Regeneration, Nerve,Regeneration, Nerve Tissue,Regeneration, Nervous Tissue,Regeneration, Neural Tissue,Tissue Regeneration, Nerve,Tissue Regeneration, Nervous,Tissue Regeneration, Neural
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005727 Ganglia, Spinal Sensory ganglia located on the dorsal spinal roots within the vertebral column. The spinal ganglion cells are pseudounipolar. The single primary branch bifurcates sending a peripheral process to carry sensory information from the periphery and a central branch which relays that information to the spinal cord or brain. Dorsal Root Ganglia,Spinal Ganglia,Dorsal Root Ganglion,Ganglion, Spinal,Ganglia, Dorsal Root,Ganglion, Dorsal Root,Spinal Ganglion
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression

Related Publications

Hiroaki Nakamura, and Yuki Domon, and Tatsuya Inoue, and Naohisa Arakawa, and Tomihisa Yokoyama
July 2011, Journal of hypertension,
Hiroaki Nakamura, and Yuki Domon, and Tatsuya Inoue, and Naohisa Arakawa, and Tomihisa Yokoyama
January 2002, Drugs,
Hiroaki Nakamura, and Yuki Domon, and Tatsuya Inoue, and Naohisa Arakawa, and Tomihisa Yokoyama
January 2009, Drugs,
Hiroaki Nakamura, and Yuki Domon, and Tatsuya Inoue, and Naohisa Arakawa, and Tomihisa Yokoyama
January 2014, Biomedical reports,
Hiroaki Nakamura, and Yuki Domon, and Tatsuya Inoue, and Naohisa Arakawa, and Tomihisa Yokoyama
July 1982, Experimental neurology,
Hiroaki Nakamura, and Yuki Domon, and Tatsuya Inoue, and Naohisa Arakawa, and Tomihisa Yokoyama
January 2016, Neuroscience letters,
Hiroaki Nakamura, and Yuki Domon, and Tatsuya Inoue, and Naohisa Arakawa, and Tomihisa Yokoyama
March 2007, The Annals of pharmacotherapy,
Hiroaki Nakamura, and Yuki Domon, and Tatsuya Inoue, and Naohisa Arakawa, and Tomihisa Yokoyama
January 1998, Microsurgery,
Hiroaki Nakamura, and Yuki Domon, and Tatsuya Inoue, and Naohisa Arakawa, and Tomihisa Yokoyama
July 2004, Diabetes,
Hiroaki Nakamura, and Yuki Domon, and Tatsuya Inoue, and Naohisa Arakawa, and Tomihisa Yokoyama
January 2013, Evidence-based complementary and alternative medicine : eCAM,
Copied contents to your clipboard!